| Early detection of metastatic relapse and monitoring of therapeutic efficacy by ultra-deep sequencing of plasma cell-free DNA in patients with urothelial bladder carcinoma E Christensen, K Birkenkamp-Demtröder, H Sethi, S Shchegrova, R Salari, ... Journal of Clinical Oncology 37 (18), 1547-1557, 2019 | 456 | 2019 |
| Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label … CN Sternberg, I Skoneczna, JM Kerst, P Albers, SD Fossa, M Agerbaek, ... The lancet oncology 16 (1), 76-86, 2015 | 419 | 2015 |
| Hypocholesterolaemic effect of a new fermented milk product in healthy middle-aged men M Agerbaek, LU Gerdes, B Richelsen European journal of clinical nutrition 49 (5), 346-352, 1995 | 297 | 1995 |
| Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort G Daugaard, MG Gundgaard, MS Mortensen, M Agerbæk, NV Holm, ... J Clin Oncol 32 (34), 3817-23, 2014 | 249 | 2014 |
| Genomic alterations in liquid biopsies from patients with bladder cancer K Birkenkamp-Demtröder, I Nordentoft, E Christensen, S Høyer, T Reinert, ... European urology 70 (1), 75-82, 2016 | 226 | 2016 |
| A nationwide cohort study of stage I seminoma patients followed on a surveillance program MS Mortensen, J Lauritsen, MG Gundgaard, M Agerbæk, NV Holm, ... European urology 66 (6), 1172-1178, 2014 | 191 | 2014 |
| Liquid biopsy analysis of FGFR3 and PIK3CA hotspot mutations for disease surveillance in bladder cancer E Christensen, K Birkenkamp-Demtröder, I Nordentoft, S Høyer, ... European urology 71 (6), 961-969, 2017 | 186 | 2017 |
| Monitoring treatment response and metastatic relapse in advanced bladder cancer by liquid biopsy analysis K Birkenkamp-Demtröder, E Christensen, I Nordentoft, M Knudsen, ... European urology 73 (4), 535-540, 2018 | 154 | 2018 |
| Distribution of early atherosclerotic lesions in the human abdominal aorta correlates with wall shear stresses measuredin vivo EM Pedersen, S Oyre, M Agerbaek, IB Kristensen, S Ringgaard, ... European journal of vascular and endovascular surgery 18 (4), 328-333, 1999 | 152 | 1999 |
| A reconstruction of the remodelling cycle in normal human cortical iliac bone MO Agerbaek, EF Eriksen, J Kragstrup, L Mosekilde, F Melsen Bone and mineral 12 (2), 101-112, 1991 | 130 | 1991 |
| miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer I Nordentoft, K Birkenkamp-Demtroder, M Agerbæk, D Theodorescu, ... BMC medical genomics 5 (1), 40, 2012 | 111 | 2012 |
| Expression of TIP60 (tat‐interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment‐specific outcome of localised invasive bladder cancer JR Laurberg, AS Brems‐Eskildsen, I Nordentoft, N Fristrup, T Schepeler, ... BJU international 110 (11c), E1228-E1236, 2012 | 108 | 2012 |
| Changes in brain structural networks and cognitive functions in testicular cancer patients receiving cisplatin-based chemotherapy A Amidi, SMH Hosseini, A Leemans, SR Kesler, M Agerbæk, LM Wu, ... JNCI: Journal of the National Cancer Institute 109 (12), djx085, 2017 | 91 | 2017 |
| Second malignant neoplasms and cause of death in patients with germ cell cancer: a Danish nationwide cohort study MG Kier, MK Hansen, J Lauritsen, MS Mortensen, M Bandak, M Agerbaek, ... JAMA oncology 2 (12), 1624-1627, 2016 | 88 | 2016 |
| Changes in cognitive functions and cerebral grey matter and their associations with inflammatory markers, endocrine markers, and APOE genotypes in testicular cancer patients … A Amidi, M Agerbæk, LM Wu, AD Pedersen, M Mehlsen, CR Clausen, ... Brain imaging and behavior 11 (3), 769-783, 2017 | 85 | 2017 |
| Normal tissue sparing in a phase II trial on daily adaptive plan selection in radiotherapy for urinary bladder cancer A Vestergaard, LP Muren, H Lindberg, KL Jakobsen, JBB Petersen, ... Acta Oncologica 53 (8), 997-1004, 2014 | 85 | 2014 |
| Cardiovascular Risk Factors and Disease After Male Germ Cell Cancer J Lauritsen, MK Hansen, M Bandak, MB Kreiberg, JW Skøtt, T Wagner, ... Journal of Clinical Oncology, JCO. 19.01180, 2019 | 84 | 2019 |
| Prognostic factors and treatment results after bleomycin, etoposide, and cisplatin in germ cell cancer: a population-based study MG Kier, J Lauritsen, MS Mortensen, M Bandak, KK Andersen, ... European urology 71 (2), 290-298, 2017 | 81 | 2017 |
| Combination of zoledronic acid and targeted therapy is active but may induce osteonecrosis of the jaw in patients with metastatic renal cell carcinoma T Smidt-Hansen, TB Folkmar, K Fode, M Agerbaek, F Donskov Journal of Oral and Maxillofacial Surgery 71 (9), 1532-1540, 2013 | 81 | 2013 |
| Optimized targeted sequencing of cell-free plasma DNA from bladder cancer patients E Christensen, I Nordentoft, S Vang, K Birkenkamp-Demtröder, JB Jensen, ... Scientific reports 8 (1), 1-11, 2018 | 60 | 2018 |